**Background:** Oxidative stress is implicated in age-related macular degeneration (AMD), but the mechanisms are unclear. Iron accumulates in the retinal pigment epithelium (RPE) of AMD patients and can catalyze reactive oxygen species (ROS) production via the Fenton reaction, leading to lipid peroxidation. The RPE is crucial for photoreceptor health, and its lysosomes are essential for digesting phagocytosed photoreceptor outer segments. Lysosomal dysfunction is thought to contribute to AMD. This study investigates the impact of iron-induced oxidative stress on RPE lysosomal function and its role in AMD pathology.
**Methods:** Human iPS-RPE cells were cultured with 50 or 100 μM FeSO4 for 6-9 weeks to model chronic iron overload. Lysosomal number (LysoTracker), proteolysis (DQ-BSA), pH (LysoSensor), and enzyme activities (cathepsin D, cathepsin B, glucosylceramidase, acid sphingomyelinase, lysosomal acid lipase) were measured. In vivo, liver-specific hepcidin knockout (LS-Hepc^KO^) mice, which develop systemic iron overload and RPE iron accumulation, were studied at 12-16 months. RPE morphology was assessed by optical coherence tomography (OCT), confocal scanning laser ophthalmoscopy (cSLO), electron microscopy (EM), and immunohistochemistry (IHC) for lysosomal markers (Lamp1, cathepsin D), LMP marker (galectin-3), lipid peroxidation products (4-HNE, CEP), and advanced glycation end products (methylglyoxal). Proteomics and lipidomics/metabolomics were performed on isolated RPE.
**Key Results:** In iPS-RPE cells, iron loading for 6 weeks significantly increased LysoTracker-positive puncta per cell (p<0.01) and decreased DQ-BSA-positive puncta per cell (p<0.01), indicating lysosomal accumulation and impaired proteolysis. Lysosomal pH was decreased (p<0.05). Cathepsin D activity was unchanged, but cathepsin B activity increased (p<0.05). Acid sphingomyelinase and lysosomal acid lipase activities decreased (p<0.05 and p<0.01, respectively), while glucosylceramidase activity was unchanged. In LS-Hepc^KO^ mice, OCT showed RPE hypertrophy and thinning of photoreceptor layers. EM revealed RPE cells packed with electron-dense, single-membrane-bound inclusions identified as lysosomes. IHC showed strong Lamp1 and cathepsin D labeling, with cathepsin D often in the cytoplasm, suggesting LMP. Galectin-3 colocalized with Lamp1 in many RPE cells, confirming LMP. Western blot of isolated RPE showed increased pro-cathepsin D, mature cathepsin D (ratio 6 times higher than controls), Lamp1 (4-fold increase), cathepsin B (17-fold increase), LC3B-II (4-fold increase), and p62 (4-fold increase), indicating lysosomal accumulation and impaired autophagy. Proteomics identified 2500 differentially expressed proteins (adjusted p<0.05), with lysosomal proteins highly enriched (e.g., cathepsin D, Lamp1, CD63). Lipidomics showed significant accumulation of ceramides (4-20 fold increase), dihydroceramides (4-14 fold), lactosylceramides (6-14 fold), lysophosphatidylcholines (LPCs), and docosahexaenoic acid (DHA) in LS-Hepc^KO^ RPE, while A2E was depleted. IHC demonstrated increased 4-HNE, CEP, and methylglyoxal in LS-Hepc^KO^ RPE, often colocalizing with Lamp1. At 16 months, LS-Hepc^KO^ mice showed RPE cell death and AMD-like morphologies including atrophy, sloughed, bilaminar, and intraretinal RPE cells.
**Clinical Implications:** This study provides a mechanistic link between iron-induced oxidative stress and RPE dysfunction in AMD. Iron overload leads to lysosomal accumulation, impaired lysosomal enzyme activity (particularly acid sphingomyelinase and lysosomal acid lipase), LMP, and accumulation of toxic lipids (ceramides) and lipid peroxidation products. These events ultimately cause RPE cell death and AMD-like pathology. The findings suggest that reducing iron levels (e.g., through chelation or dietary changes), inhibiting lipid peroxidation (e.g., with deuterated DHA), or enhancing lysosomal function could be therapeutic strategies for AMD. The study also highlights the potential role of ceramide metabolism and LMP as targets for intervention.